ACADIA PHARMACEUTICALS INC stock forecast: down to 23.13 USD ACAD stock price prognosis


Forecast for Fri 17 Nov 2023 price 23.35

ACADIA PHARMACEUTICALS INC stock price forecast for further price development down to -9.82% (time horizon: 1 day) and price target of 23.13 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ACADIA PHARMACEUTICALS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol ACAD 

ISIN US0042251084 

CUSIP 004225108

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.30)

News <--> Close correlation for next day influence (0.15)

Finance numbers

Revenue 458,241,000.0

Earnings per share -1.64

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

We hold worldwide commercialization rights to pimavanserin. Currently, there are no approved medicines for the treatment of Rett syndrome. Our PDUFA target action date is April 3, 2021. Two of four commitments are already completed within the agreed upon timelines. Discontinuations due to adverse events were 2.9% for pimavanserin and 3.6% for placebo. The sNDA is supported by results from the pivotal Phase 3 HARMONY study. Our failure to compete effectively could have a material adverse effect on our business. These patent terms include adjustments made by the PTO, but not extensions. Coverage policies and third-party payor reimbursement rates may change at any time. We added 98 new employees in 2020. Employee Engagement, Benefits & Development. We initiated the Phase 3 LAVENDER study of trofinetide for Rett syndrome in October 2019. Additionally, NUPLAZID is still subject to substantial, ongoing regulatory requirements. There is no guarantee that future studies with pimavanserin will be successful. As of December 31, 2020, we employed approximately 600 employees. This could have a material adverse effect on our ability to access sufficient funding. On December 10, 2020, we filed our answer to MSN's counterclaims. It is difficult to determine how such disputes would be resolved. As a result, we may be subject to criminal and civil liability. Even successful defense would require significant financial and management resources. Defendants filed a motion to dismiss the consolidated complaint on June 7, 2019. Lead plaintiff opposed the motion on September 15, 2020. 20-cv-0843) was filed in the U.S. District Court for the District of Delaware.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 65.10/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 189540
China Universal Asset Management Co., Ltd. 2023-06-30 2132
NATIXIS 2022-12-31 1

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Mt. Vernon Street Trust 2023-02-28 935871 Long
Fidelity Concord Street Trust 2023-02-28 95418 Long
Fidelity Commonwealth Trust 2023-02-28 67579 Long
Fidelity Mt. Vernon Street Trust 2023-02-28 816392 Long
Fidelity Concord Street Trust 2023-02-28 615705 Long


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1746240 Kim Austin D. 2023-04-06 SALE Accept Accept Accept Accept
1432545 Stankovic Srdjan R. 2022-10-15 SALE Accept Accept Accept Accept
1816160 Kihara James 2023-04-06 SALE Accept Accept Accept Accept
1891900 Teehan Brendan 2023-04-06 SALE Accept Accept Accept Accept
1899977 Schneyer Mark C. 2023-04-06 SALE Accept Accept Accept Accept

Bollinger Bollinger Bands for ACADIA PHARMACEUTICALS INC can provide the information where the market is moving based on price information.

ACADIA PHARMACEUTICALS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns ACADIA PHARMACEUTICALS INC.

On-Balance Volume information for ACADIA PHARMACEUTICALS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ACADIA PHARMACEUTICALS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ACADIA PHARMACEUTICALS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ACADIA PHARMACEUTICALS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ACADIA PHARMACEUTICALS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ACADIA PHARMACEUTICALS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ACADIA PHARMACEUTICALS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-13 23.13 2023-09-23 07:28
2023-09-29 23.44 2023-09-23 07:28
2023-09-25 23.48 2023-09-23 07:28
2023-10-20 23.15 2023-09-23 07:28
2023-09-26 23.56 2023-09-23 07:28
2023-10-04 23.38 2023-09-23 07:28
2023-10-05 23.38 2023-09-23 07:28
2023-11-08 23.26 2023-09-23 07:28
2023-11-02 23.22 2023-09-23 07:28
2023-09-27 23.52 2023-09-23 07:28
2023-10-18 23.13 2023-09-23 07:28
2023-10-02 23.38 2023-09-23 07:28
2023-10-03 23.35 2023-09-23 07:28
2023-10-16 23.11 2023-09-23 07:28
2023-10-17 23.11 2023-09-23 07:28
2023-09-28 23.42 2023-09-23 07:28
2023-10-06 23.33 2023-09-23 07:28
2023-10-27 23.18 2023-09-23 07:28
2023-10-23 23.15 2023-09-23 07:28
2023-10-24 23.15 2023-09-23 07:28
2023-10-09 23.30 2023-09-23 07:28
2023-10-10 23.26 2023-09-23 07:28
2023-11-03 23.23 2023-09-23 07:28
2023-11-15 23.32 2023-09-23 07:28
2023-10-11 23.18 2023-09-23 07:28
2023-10-12 23.15 2023-09-23 07:28
2023-10-19 23.14 2023-09-23 07:28
2023-11-09 23.27 2023-09-23 07:28
2023-10-25 23.16 2023-09-23 07:28
2023-11-06 23.24 2023-09-23 07:28
2023-10-30 23.20 2023-09-23 07:28
2023-10-31 23.21 2023-09-23 07:28
2023-11-01 23.22 2023-09-23 07:28
2023-10-26 23.17 2023-09-23 07:28
2023-11-07 23.25 2023-09-23 07:28
2023-11-13 23.30 2023-09-23 07:28
2023-11-14 23.31 2023-09-23 07:28
2023-11-16 23.34 2023-09-23 07:28
2023-11-10 23.29 2023-09-23 07:28
2023-11-17 23.35 2023-09-23 07:28
Table bellow show Bot decisions related with product
Decision Date Chart Link/Company Name Bot Decision Money # Portfolio Value
2021-03-10 Acadia Pharmaceuticals Inc buy 36.62 63 1730.69
2021-03-11 Acadia Pharmaceuticals Inc hold 36.62 63 1721.87
2021-03-12 Acadia Pharmaceuticals Inc hold 36.62 63 1740.14
2021-03-15 Acadia Pharmaceuticals Inc hold 36.62 63 1925.99
2021-03-16 Acadia Pharmaceuticals Inc sell 1739.04 0 1739.04

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.